The Change of Quantitative of HBeAg Can Predict the Efficacy of Peg-IFN-α 2a in HBeAgpositive CHB Patients
Yong-jian Ji(Dezhou University), Chengyong Qin(Shandong Provincial Hospital), Jianting Fang(Shandong University), Xizhen Sun(Shandong University), Feifei Li(National Clinical Research), Wanhua Ren(Shandong University)
Infection International/Infection International (Electronic Edition)
September 1, 2013
Cited by 0
Related Papers
Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome
|World Journal of Gastroenterology|2003|142
lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma
|International Journal of Oncology|2018|73
Suppression of Cholangiocarcinoma Cell Growth by Human Umbilical Cord Mesenchymal Stem Cells: A Possible Role of Wnt and Akt Signaling
|PLoS ONE|2013|66
Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells
|Journal of Experimental & Clinical Cancer Research|2009|48